Literature DB >> 34177429

Deciphering the Pathogenic Nature of Two de novo Sequence Variations in a Patient with Shprintzen-Goldberg Syndrome.

Priyanka Srivastava1, Shashank Shende2, Kausik Mandal2.   

Abstract

Shprintzen-Goldberg syndrome (SGS) is autosomal dominant disorder with features of craniosynostosis, distinctive craniofacial features, skeletal abnormalities, marfanoid body habitus, aortic dilatation, and intellectual disability. SGS is caused by mutations in the SKI gene, encoding the oncoprotein SKI, a repressor of TGFβ activity. We present the unusual molecular findings in a 12-year-old female child with SGS. There was co-occurrence of 2 heterozygous missense variations, c.346G>A (p.Gly116Arg) and c.687G>C (p.Lys229Asn), in exon 1 (hotspot) of the SKI gene, which makes this propositus different from all other patients reported in the literature. Both variants were found to be de novo. In silico analysis revealed that both of them are pathogenic, but later on, Gly116Arg was proven to be more pathogenic by various in silico prediction tools. c.687G>C (p.Lys229Asn) was found as a single report in ExAC in the South Asian population, but c.346G>A (p.Gly116Arg) is not reported anywhere, thereby making it a novel sequence variant in the SKI gene, giving rise to SGS. This case illustrates the issues regarding the importance and difficulties associated with the determination of the causative variations in a single-gene disorder.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Co-occurrence; Novel; Sanger sequencing; Shprintzen-Goldberg syndrome; de novo

Year:  2021        PMID: 34177429      PMCID: PMC8215994          DOI: 10.1159/000514125

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  11 in total

1.  Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.

Authors:  Jia Wei Wu; Ariel R Krawitz; Jijie Chai; Wenyu Li; Fangjiu Zhang; Kunxin Luo; Yigong Shi
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

4.  Methods for determining spontaneous mutation rates.

Authors:  Patricia L Foster
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 5.  De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome: two new cases and a clinical review.

Authors:  P Y Billie Au; Hilary E Racher; John M Graham; Nancy Kramer; R Brian Lowry; Jillian S Parboosingh; A Micheil Innes
Journal:  Am J Med Genet A       Date:  2013-12-19       Impact factor: 2.802

Review 6.  Rates of spontaneous mutation.

Authors:  J W Drake; B Charlesworth; D Charlesworth; J F Crow
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

7.  The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome.

Authors:  Dorien Schepers; Alexander J Doyle; Gretchen Oswald; Elizabeth Sparks; Loretha Myers; Patrick J Willems; Sahar Mansour; Michael A Simpson; Helena Frysira; Anneke Maat-Kievit; Rick Van Minkelen; Jeanette M Hoogeboom; Geert R Mortier; Hannah Titheradge; Louise Brueton; Lois Starr; Zornitza Stark; Charlotte Ockeloen; Charles Marques Lourenco; Ed Blair; Emma Hobson; Jane Hurst; Isabelle Maystadt; Anne Destrée; Katta M Girisha; Michelle Miller; Harry C Dietz; Bart Loeys; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2014-04-16       Impact factor: 4.246

Review 8.  Distinct skeletal abnormalities in four girls with Shprintzen-Goldberg syndrome.

Authors:  L C Adès; L L Morris; R G Power; M Wilson; E A Haan; J F Bateman; D M Milewicz; D O Sillence
Journal:  Am J Med Genet       Date:  1995-07-17

9.  In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.

Authors:  Virginie Carmignac; Julien Thevenon; Lesley Adès; Bert Callewaert; Sophie Julia; Christel Thauvin-Robinet; Lucie Gueneau; Jean-Benoit Courcet; Estelle Lopez; Katherine Holman; Marjolijn Renard; Henri Plauchu; Ghislaine Plessis; Julie De Backer; Anne Child; Gavin Arno; Laurence Duplomb; Patrick Callier; Bernard Aral; Pierre Vabres; Nadège Gigot; Eloisa Arbustini; Maurizia Grasso; Peter N Robinson; Cyril Goizet; Clarisse Baumann; Maja Di Rocco; Jaime Sanchez Del Pozo; Frédéric Huet; Guillaume Jondeau; Gwenaëlle Collod-Beroud; Christophe Beroud; Jeanne Amiel; Valérie Cormier-Daire; Jean-Baptiste Rivière; Catherine Boileau; Anne De Paepe; Laurence Faivre
Journal:  Am J Hum Genet       Date:  2012-10-25       Impact factor: 11.025

10.  Structures of native human thymidine phosphorylase and in complex with 5-iodouracil.

Authors:  Eirini Mitsiki; Anastassios C Papageorgiou; Shalini Iyer; Nethaji Thiyagarajan; Steven H Prior; Darrell Sleep; Chris Finnis; K Ravi Acharya
Journal:  Biochem Biophys Res Commun       Date:  2009-06-23       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.